您的位置 : 环球研究 / 环球报告 / 研究报告 / 新闻详情
环球连续受钱伯斯邀请撰写《药品广告法律与实践2021》之中国篇
2021年05月08日周磊 | 黄旭春 | 何璇 | 崔洋

受国际权威法律评级机构钱伯斯(Chambers and Partners)邀请,环球律师事务所连续第三年为其撰写《全球法律指南》系列中的《药品广告法律与实践(2021版)》之中国篇。为促进信息分享和交流,钱伯斯排行榜中的领先律所将可能受邀参与撰写法律指南。

 

Chambers and Partners, one of the most authoritative international legal ranking agencies, invited Global Law Office to contribute to the Pharmaceutical Advertising 2021 (China Chapter) for the third consecutive year. Pharmaceutical Advertising 2021 is a part of the Chambers Global Practice Guide Series. To facilitate information communication and sharing, reputable and leading law firms ranked by Chambers and Partners could be invited to contribute to the guide.

 

此次《药品广告法律与实践(2021版)》之中国篇由环球律师事务所合伙人周磊黄旭春,顾问律师何璇、律师崔洋撰写。该指南中着重介绍了中国法律下的药品广告监管框架,药品广告的认定、申请、审核、发布等的监管要求,药品广告的执法趋势,以及企业日常合规管理中的关注点等。如果您希望就本指南或者与本指南讨论的内容进一步交流,敬请联系撰文作者。

 

The Pharmaceutical Advertising 2021 (China Chapter) is drafted by legal professionals at Global Law Office, namely Partners Alan Zhou and Charlene Huang, Of Counsel Samantha He and Associate Cui Yang. The guide outlines the regulatory framework of pharmaceutical advertising under PRC law, introduces the regulatory requirements related to definition, application, approval, and release of pharmaceutical advertisement, illustrates the regulatory enforcement trends, and summarizes key points that companies may consider to prevent and deal with non-compliance conducts in daily operation. If you have any inquiries or comments about the publication or related issues, please feel free to contact the authors. 

相关下载